ANI Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of December 2025: 0.63%

ANI Pharmaceuticals Inc (ANIP) has an Asset Resilience Ratio of 0.63% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$9.13 Million

Cash + Short-term Investments

Total Assets

$1.44 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2025)

This chart shows how ANI Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Check ANI Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down ANI Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ANI Pharmaceuticals Inc market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$9.13 Million	0.63%
Total Liquid Assets	$9.13 Million	0.63%

Asset Resilience Insights

Limited Liquidity: ANI Pharmaceuticals Inc maintains only 0.63% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ANI Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare ANI Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
Akums Drugs and Pharmaceutical NSE:AKUMS	Drug Manufacturers - Specialty & Generic	28.08%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Tibet Weixinkang Medicine Co Ltd SHG:603676	Drug Manufacturers - Specialty & Generic	40.81%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for ANI Pharmaceuticals Inc (2004–2025)

The table below shows the annual Asset Resilience Ratio data for ANI Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.63%	$9.13 Million	$1.44 Billion	+0.14pp
2024-12-31	0.49%	$6.31 Million	$1.28 Billion	--
2023-12-31	0.00%	$0.00	$904.42 Million	--
2017-12-31	0.00%	$0.00	$412.14 Million	--
2016-12-31	0.00%	$0.00	$322.86 Million	--
2015-12-31	0.00%	$0.00	$285.26 Million	--
2014-12-31	0.00%	$0.00	$263.71 Million	--
2013-12-31	0.00%	$0.00	$44.50 Million	--
2012-12-31	0.00%	$0.00	$38.77 Million	--
2011-12-31	0.00%	$0.00	$62.38 Million	--
2008-12-31	17.12%	$3.03 Million	$17.68 Million	-30.91pp
2007-12-31	48.03%	$15.01 Million	$31.24 Million	+31.06pp
2006-12-31	16.97%	$3.80 Million	$22.37 Million	-74.85pp
2005-12-31	91.82%	$8.79 Million	$9.57 Million	+1.51pp
2004-12-31	90.30%	$16.10 Million	$17.83 Million	--

pp = percentage points

About ANI Pharmaceuticals Inc

NASDAQ:ANIP USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.74 Billion

Market Cap Rank

#6556 Global

#2054 in USA

Share Price

$77.61

Change (1 day)

-1.95%

52-Week Range

$63.35 - $98.81

All Time High

$98.81